United States (US) Graves' Disease Market (2025-2031) | Share, Competitive Landscape, Outlook, Size & Revenue, Companies, Segmentation, Industry, Trends, Value, Forecast, Growth, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Graves' Disease Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Graves' Disease Market - Industry Life Cycle

3.4 United States (US) Graves' Disease Market - Porter's Five Forces

3.5 United States (US) Graves' Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F

3.6 United States (US) Graves' Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of Graves' disease in the United States

4.2.2 Growing awareness and diagnosis rates of autoimmune diseases

4.2.3 Technological advancements in diagnostic tools and treatment options

4.3 Market Restraints

4.3.1 High cost of treatment and medications for Graves' disease

4.3.2 Limited availability of specialized healthcare professionals for managing Graves' disease

4.3.3 Stringent regulatory requirements for approval of new treatments

6.1 United States (US) Graves' Disease Market, By Diagnosis

6.1.1 Overview and Analysis

6.1.2 United States (US) Graves' Disease Market Revenues & Volume, By Diagnosis, 2021- 2031F

6.1.3 United States (US) Graves' Disease Market Revenues & Volume, By Ultrasound, 2021- 2031F

6.1.4 United States (US) Graves' Disease Market Revenues & Volume, By Imaging Test, 2021- 2031F

6.1.5 United States (US) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Uptake, 2021- 2031F

6.1.6 United States (US) Graves' Disease Market Revenues & Volume, By Blood Sample, 2021- 2031F

6.2 United States (US) Graves' Disease Market, By Treatment

6.2.1 Overview and Analysis

6.2.2 United States (US) Graves' Disease Market Revenues & Volume, By Anti-Thyroid Medication, 2021- 2031F

6.2.3 United States (US) Graves' Disease Market Revenues & Volume, By Radioactive Iodine Therapy, 2021- 2031F

6.2.4 United States (US) Graves' Disease Market Revenues & Volume, By Surgery, 2021- 2031F

7.1 United States (US) Graves' Disease Market Export to Major Countries

7.2 United States (US) Graves' Disease Market Imports from Major Countries

8.1 Average time to diagnosis of Graves' disease

8.2 Patient adherence to prescribed treatment plans

8.3 Number of research studies and clinical trials conducted for Graves' disease

8.4 Rate of adoption of new treatment modalities

8.5 Patient satisfaction with healthcare services for Graves' disease

9.1 United States (US) Graves' Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F

9.2 United States (US) Graves' Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F

10.1 United States (US) Graves' Disease Market Revenue Share, By Companies, 2024

10.2 United States (US) Graves' Disease Market Competitive Benchmarking, By Operating and Technical Parameters